Dr. Drew S. Dill, MD

Dr. Dill practices at Baptist Memorial Hospital-Tipton in Covington, Tennessee, part of Baptist Memorial Health Care.

Dr. Dill's NPI, 1578723276, was assigned on June 16, 2008. Dr. Dill graduated from VCU School of Medicine in 2008. Dr. Dill holds Tennessee license 48960.

Dr. Dill's primary practice is Baptist Memorial Hospital-Tipton, at 1995 Highway 51 S, Covington, TN 38019 in Tipton County. The practice phone is (901) 476-2621.

Dr. Dill's primary practice is Baptist Memorial Hospital-Tipton in Covington, Tennessee, part of Baptist Memorial Health Care. Dr. Dill is also affiliated with Methodist University Hospital. The medical group on file is Baptist Medical Group. Dmand AI also links Dr. Dill to 5 more hospitals, 5 medical groups, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dill practices, 9 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dill's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dill is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Dill's licenses on file in 5 states: Tennessee, Arkansas, Mississippi, Florida and Virginia.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), immune deficiency disease, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Dill treats.

CMS data shows 2,518 Medicare services from Dr. Dill across 9 procedure codes in 2024, for 765 Medicare patients. Medicare paid $151,487 for them.

CMS counts 765 Medicare patients who saw Dr. Dill in 2024. The largest group is 65 to 74, with 301 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dill's median patient age at 74, with 69% women.

In 2024, Dr. Dill wrote 2,301 Medicare Part D claims for 367 patients. 70% of them were for generic drugs. CMS names the drug for 1,928 of them, across 43 drugs with 11 or more claims each, at $5,230,716 in total drug cost. In 2023, CMS named 1,804 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Dill for performance year 2024, reported as part of a group. Dr. Dill accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Dill. Dr. Dill's most frequent co-authors are Phillip John Link, MD, Shirin Mazumder, MD and Zachary E. Stiles, DO.

Dmand AI links Dr. Dill to 4 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Adenocarcinoma, Bronchiolo-Alveolar, Memory Disorders and Triple Negative Breast Neoplasms. ECOG-ACRIN Cancer Research Group sponsors the most, 2.

CMS Open Payments shows 803 general payments to Dr. Dill from 59 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Bristol-Myers Squibb Company paid the most, $1,313.

Dmand AI lists 1 award for Dr. Dill, most recently CMS Stage 1 EHR in 2014.

Dr. Dill graduated from VCU School of Medicine in 2008.

Dr. Dill is in network with 16 carriers, including Aetna, Elevance and Cigna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.